Longitudinal study of low serum LDL cholesterol and depressive symptom onset in postmenopause

Journal of Clinical Psychiatry

Volumn 77, Issue 2, 2016, Pages 212-220

  Persons, Jane E ^a   Robinson, Jennifer G ^a,b   Coryell, William H ^c   Payne, Martha E ^d   Fiedorowicz, Jess G ^a,b,c  

^a UNIVERSITY OF IOWA   (United States)

^b Departments of Internal Medicine   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; BILE ACID SEQUESTRANT; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID DERIVATIVE;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; DEPRESSION; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; BLOOD; MIDDLE AGED; ONSET AGE;

AGE OF ONSET; AGED; CHOLESTEROL, LDL; DEPRESSION; FEMALE; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; POSTMENOPAUSE;

EID: 84959559454     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.14m09505     Document Type: Article

References (49)

1. Coryell W, Schlesser M.combined biological tests for suicide prediction. Psychiatry Res. 2007;150(2):187-191. doi:10.1016/j.psychres.206.01.021 PubMed
2. Conwell Y, Duberstein PR, Caine ED. Risk factors for suicide in later life. Biol Psychiatry. 2002;52(3):193-204. doi:10.1016/S06-323(02)01347-1 PubMed
3. Scanlon SM, Williams DC, Schloss P. Membrane cholesterol modulates serotonin transporter activity. Biochemistry. 2001;40(35):10507-10513. doi:10.1021/bi010730z PubMed
4. Shin JY, Suls J, Martin R. Are cholesterol and depression inversely related? a meta-analysis of the association between two cardiac risk factors. Ann Behav Med. 2008;36(1):33-43. doi:10.107/s12160-08-9045-8 PubMed
5. Nakao M, Yano E. Relationship between major depression and high serum cholesterol in Japanese men. Tohoku J Exp Med. 2004;204(4):273-287. doi:10.1620/tjem.204.273 PubMed
6. Liang Y, Yan Z, Cai C, et al. Association between lipid profile and depressive symptoms among Chinese older people: Mediation by cardiovascular diseases? Int J Behav Med. 2014;21(4):590-596. PubMed
7. Kardys I, Oei HH, Van Der Meer IM, et al. Lipoprotein-associated phospholipase A2 and measures of extracoronary atherosclerosis: The Rotterdam Study. Arterioscler Thromb Vasc Biol. 2006;26(3):631-636. doi:10.161/01.ATV.0201289.83256.cf PubMed
8. Aijänseppä S, Kivinen P, Helkala EL, et al. Serum cholesterol and depressive symptoms in elderly Finnish men. Int J Geriatr Psychiatry. 2002;17(7):629-634. doi:10.102/gps.6 PubMed
9. Igna CV, Julkunen J, Vanhanen H, et al. Depressive symptoms and serum lipid fractions in middle-aged men: Physiologic and health behavior links. Psychosom Med. 2008;70(9):960-966. doi:10.1097/PSY.0b013e318189a942 PubMed
10. Fiedorowicz JG, Haynes WG. Cholesterol, mood, and vascular health: Untangling the relationship: Does low cholesterol predispose to depression and suicide, or vice versa? Curr Psychiatr. 2010;9(7):17. PubMed
11. Horsten M, Wamala SP, Vingerhoets A, et al. Depressive symptoms, social support, and lipid profile in healthy middle-aged women. Psychosom Med. 1997;59(5):521-528. doi:10.1097/06842-197090-09 PubMed
12. Henderson VW, Guthrie JR, Dennerstein L. Serum lipids and memory in a population based cohort of middle age women. J Neurol Neurosurg Psychiatry. 2003;74(11):1530-1535. doi:10.136/jnp.74.1.1530 PubMed
13. Fang CY, Egleston BL, Gabriel KP, et al. Depressive symptoms and serum lipid levels in young adult women. J Behav Med. 2013;36(2):143-152. doi:10.107/s10865-012-9409-1 PubMed
14. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Control Clin Trials. 1998;19(1):61-109. doi:10.1016/S0197-2456(97)078-0 PubMed
15. Carty CL, Johnson NA, Hutter CM, et al. Genome-wide association study of body height in African Americans: The Women's Health Initiative SNP Health Association Resource (SHARe). Hum Mol Genet. 2012;21(3):711-720. doi:10.1093/hmg/dr489 PubMed
16. Chen CT, Fernández-Rhodes L, Brzyski RG, et al. Replication of loci influencing ages at menarche and menopause in Hispanic women: The Women's Health Initiative SHARe Study. Hum Mol Genet. 2012;21(6):1419-1432. doi:10.1093/hmg/dr570 PubMed
17. Shumaker SA, Legault C, Kuller L, et al; Women's Health Initiative Memory Study. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA. 2004;291(24):2947-2958. doi:10.101/jama.291.24.2947 PubMed
18. Bray PF, Larson JC, Lacroix AZ, et al; Women's Health Initiative Investigators. Usefulness of baseline lipids and C-reactive protein in women receiving menopausal hormone therapy as predictors of treatment-related coronary events. Am J Cardiol. 2008;101(11):1599-1605, 1605.e1. doi:10.1016/j.amjcard.208.01.043 PubMed
19. Rossouw JE, Cushman M, Greenland P, et al. Inflammatory, lipid, thrombotic, and genetic markers of coronary heart disease risk in the women's health initiative trials of hormone therapy. Arch Intern Med. 2008;168(20):2245-2253. doi:10.101/archinte.168.20.245 PubMed
20. Burnam MA, Wells KB, Leake B, et al. Development of a brief screening instrument for detecting depressive disorders. Med Care. 1988;26(8):775-789. doi:10.1097/05650-198080-04 PubMed
21. Goveas JS, Espeland MA, Hogan P, et al. Depressive symptoms, brain volumes and subclinical cerebrovascular disease in postmenopausal women: The Women's Health Initiative MRI Study. J Affect Disord. 2011;132(1-2):275-284. doi:10.1016/j.jad.201.01.020 PubMed
22. Bertone-Johnson ER, Powers SI, Spangler L, et al. Vitamin D intake from foods and supplements and depressive symptoms in a diverse population of older women. Am J Clin Nutr. 2011;94(4):1104-1112. doi:10.3945/ajcn.1.017384 PubMed
23. Persons JE, Robinson JG, Ammann EM, et al. Omega-3 fatty acid biomarkers and subsequent depressive symptoms. Int J Geriatr Psychiatry. 2014;29(7):747-757. PubMed
24. Lakey SL, LaCroix AZ, Gray SL, et al. Antidepressant use, depressive symptoms, and incident frailty in women aged 65 and older from the Women's Health Initiative Observational Study. J Am Geriatr Soc. 2012;60(5):854-861. doi:10.1/j.1532-5415.2012.03940.x PubMed
25. McQuellon RP, Wells M, Hoffman S, et al. Reducing distress in cancer patients with an orientation program. Psychooncology. 1998;7(3):207-217. doi:10.102/(SICI)109-161(19805/06)7:33.0.CO;2-T PubMed
26. Samsa GP, Cohen SJ, Goldstein LB, et al. Knowledge of risk among patients at increased risk for stroke. Stroke. 1997;28(5):916-921. doi:10.161/01.STR.28.5.916 PubMed
27. Lynch DJ, Tamburrino MB, Nagel R. Telephone counseling for patients with minor depression: Preliminary findings in a family practice setting. J Fam Pract. 1997;44(3):293-298. PubMed
28. Houghton A, Bowling A, Clarke KD, et al. Does a dedicated discharge coordinator improve the quality of hospital discharge? Qual Health Care. 1996;5(2):89-96. doi:10.136/qshc.5.2.89 PubMed
29. Johnson RE, Hornbrook MC, Nichols GA. Replicating the chronic disease score (CDS) from automated pharmacy data. J Clin Epidemiol. 1994;47(10):1191-1199. doi:10.1016/0895-4356(94)90106-6 PubMed
30. Kemper KJ, Osborn LM, Hansen DF, et al. Family psychosocial screening: Should we focus on high-risk settings? J Dev Behav Pediatr. 1994;15(5):336-341. doi:10.1097/04703-19410-04 PubMed
31. Mulrow CD, Williams JW Jr, Gerety MB, et al. Case-finding instruments for depression in primary care settings. Ann Intern Med. 1995;122(12):913-921. doi:10.7326/03-4819-12-19506150-04 PubMed
32. Watson JM, Kemper KJ. Maternal factors and child's health care use. Soc Sci Med. 1995;40(5):623-628. doi:10.1016/027-9536(95)806-6 PubMed
33. Duncan PW, Samsa GP, Weinberger M, et al. Health status of individuals with mild stroke. Stroke. 1997;28(4):740-745. doi:10.161/01.STR.28.4.740 PubMed
34. Archer DF, Seidman L, Constantine GD, et al. A double-blind, randomly assigned, placebo-controlled study of desvenlafaxine efficacy and safety for the treatment of vasomotor symptoms associated with menopause. Am J Obstet Gynecol. 2009;200(2):e1-e10. doi:10.1016/j.ajog.208.09.87 PubMed
35. Freeman EW, Guthrie KA, Caan B, et al. Efficacy of escitalopram for hot flashes in healthy menopausal women: A randomized controlled trial. JAMA. 2011;305(3):267-274. doi:10.101/jama.2010.2016 PubMed
36. Pinkerton JV, Archer DF, Guico-Pabia CJ, et al. Maintenance of the efficacy of desvenlafaxine in menopausal vasomotor symptoms: A 1-year randomized controlled trial. Menopause. 2013;20(1):38-46. doi:10.1097/gme.0b013e31826421a8 PubMed
37. Hummel J, Westphal S, Weber-Hamann B, et al. Serum lipoproteins improve after successful pharmacologic antidepressant treatment: A randomized open-label prospective trial. J Clin Psychiatry. 2011;72(7):885-891. doi:10.408/JCP.09m05853blu PubMed
38. Raeder MB, Bjelland I, Emil Vollset S, et al. Obesity, dyslipidemia, and diabetes with selective serotonin reuptake inhibitors: The Hordaland Health Study. J Clin Psychiatry. 2006;67(12):1974-1982. doi:10.408/JCP.v67n1219 PubMed
39. Margolis KL, Lihong Qi, Brzyski R, et al; Women Health Initiative Investigators. Validity of diabetes self-reports in the Women's Health Initiative: Comparison with medication inventories and fasting glucose measurements. Clin Trials. 2008;5(3):240-247. doi:10.17/174074508091749 PubMed
40. Physical status: The use and interpretation of anthropometry: Report of a WHO Expert Committee. World Health Organ Tech Rep Ser. 1995;854:1-452. PubMed
41. Chobanian AV, Bakris GL, Black HR, et al; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA. 2003;289(19):2560-2572. doi:10.101/jama.289.19.2560 PubMed
42. Ainsworth BE, Haskell WL, Leon AS, et al.compendium of physical activities: Classification of energy costs of human physical activities. Med Sci Sports Exerc. 1993;25(1):71-80. doi:10.1249/05768-193010-01 PubMed
43. McGuire S. US Department of Agriculture and US Department of Health and Human Services, Dietary Guidelines for Americans, 2010. 7th Edition, Washington, DC: US Government Printing Office, January 2011. Adv Nutr. 2011;2(3):293-294. doi:10.3945/an.1.0430 PubMed
44. Stone NJ, Robinson J, Lichtenstein AH, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129 (suppl 2):S1-S45. PubMed
45. Dormuth CR, Patrick AR, Shrank WH, et al. Statin adherence and risk of accidents: A cautionary tale. Circulation. 2009;119(15):2051-2057. doi:10.161/CIRCULATIONAHA.108.824151 PubMed
46. Lester D. Serum cholesterol levels and suicide: A meta-analysis. Suicide Life Threat Behav. 2002;32(3):333-346. doi:10.1521/suli.32.3.3.217 PubMed
47. Huffman JC, Stern TA. Neuropsychiatric consequences of cardiovascular medications. Dialogues Clin Neurosci. 2007;9(1):29-45. PubMed
48. Law MR, Thompson SG, Wald NJ. Assessing possible hazards of reducing serum cholesterol. BMJ. 1994;308(6925):373-379. doi:10.136/bmj.308.6925.373 PubMed
49. Sahebzamani FM, D'Aoust RF, Friedrich D, et al. Relationship among low cholesterol levels, depressive symptoms, aggression, hostility, and cynicism. J Clin Lipidol. 2013;7(3):208-216. doi:10.1016/j.jacl.2013.01.04 PubMed